Germline MC1R variants, in particular the R alleles, have also been associated with higher tumor mutational burden (TMB) in primary melanoma tumors (Johansson et al. 2017; Robles‐Espinoza et al. 2016). This evidence concerns the gene MC1R and neoplasm.